Literature DB >> 10488057

Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits.

P Ping1, J Zhang, Y T Zheng, R C Li, B Dawn, X L Tang, H Takano, Z Balafanova, R Bolli.   

Abstract

Src tyrosine kinases have been shown to mediate cellular responses to stress in noncardiac cells. However, the effect of myocardial ischemia on Src tyrosine kinases is unknown. Furthermore, the identity of the tyrosine kinase(s) involved in the genesis of ischemic preconditioning (PC) remains obscure. Here, we present the first evidence that ischemic PC (6 cycles of 4-minute coronary occlusion and 4-minute reperfusion) induces selective activation of 2 members of the Src family of tyrosine kinases, Src and Lck, in the heart of conscious rabbits. The activation of Src in the particulate fraction was not evident at 5 minutes after ischemic PC but became apparent at 30 minutes (+119% versus control), whereas the activation of Lck in the particulate fraction was apparent both at 5 minutes (+103% versus control) and at 30 minutes (+89%) after ischemic PC. The activity of the other 5 members of the Src tyrosine kinases expressed in the rabbit heart (Fyn, Fgr, Yes, Lyn, and Blk) was not affected by ischemic PC. Ischemic PC had no effect on the activity of epidermal growth factor receptor kinases, either at 5 or at 30 minutes. The activation of Src and Lck was completely abrogated by the tyrosine kinase inhibitor lavendustin A, given at doses that have previously been shown to block the protective effect of ischemic PC in this same conscious rabbit model, suggesting that Src and Lck kinases are essential for the development of ischemic PC. The activity of the epsilon isoform of protein kinase C (PKC) in the particulate fraction increased at 5 minutes (+72%) and at 30 minutes (+67%) after ischemic PC. Pretreatment with lavendustin A had no effect on the activation of PKCepsilon, whereas pretreatment with the PKC inhibitor chelerythrine (given at doses that have previously been shown to block ischemic PC) blocked not only the activation of PKCepsilon but also that of Src and Lck, indicating that Src and Lck are downstream of PKCepsilon in the signaling cascade of ischemic PC. This study identifies a new component of the signaling mechanism of ischemic PC. The results support the concept that, in conscious rabbits, 2 specific members of the Src family of tyrosine kinases, Src and Lck, play an important role in the genesis of late PC by serving as downstream elements of PKC-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10488057     DOI: 10.1161/01.res.85.6.542

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  35 in total

1.  Lymphocyte cell kinase activation mediates neuroprotection during ischemic preconditioning.

Authors:  Ok-Nam Bae; Krishnamurthy Rajanikant; Jiangyong Min; Jeremy Smith; Seung-Hoon Baek; Kelsey Serfozo; Siamak Hejabian; Ki Yong Lee; Mounzer Kassab; Arshad Majid
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 2.  Organ preconditioning: the past, current status, and related lung studies.

Authors:  Shi-ping Luh; Pan-chyr Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

3.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

4.  PKC alpha-dependent regulation of the IGF1 receptor in adult and embryonic rat cardiomyocytes.

Authors:  Ruchita Maniar; Anna Pecherskaya; Richard Ila; Michele Solem
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

6.  NADPH oxidase in vascular injury: a new insight about its regulation and role in T cells.

Authors:  Jun-ichi Abe; Chang-Hoon Woo
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

Review 7.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

8.  Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway.

Authors:  Jie Ren; Wei Liu; Guang-Cai Li; Meng Jin; Zhen-Xi You; Hui-Guo Liu; Yi Hu
Journal:  Curr Med Sci       Date:  2018-06-22

9.  Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria.

Authors:  Jianhua Feng; Eliana Lucchinetti; Giray Enkavi; Yi Wang; Peter Gehrig; Bernd Roschitzki; Marcus C Schaub; Emad Tajkhorshid; Kathrin Zaugg; Michael Zaugg
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

10.  Mechanism of cyclooxygenase-2 upregulation in late preconditioning.

Authors:  Yu-Ting Xuan; Yiru Guo; Yanqing Zhu; Hui Han; Robert Langenbach; Buddhadeb Dawn; Roberto Bolli
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.